Yet problematic pharmacies continued to advertise on Google, according to Carmen Catizone, NABP's executive director, as well as several other researchers.
WSJ: Google Was Warned on Rogue Drug Ads
2.
"The FDA program will only cause more confusion, increase the cost of enforcement and at the same time make it less effective, " Catizone said.
FORBES: Drug wars
3.
"The FDA doesn't have the resources or the expertise to handle this kind of thing, " said Carmen Catizone, executive director of the National Association of the Boards of Pharmacy (NABP), which represents the state pharmacy boards.